GB2172889A - Phosphoric esters - Google Patents
Phosphoric esters Download PDFInfo
- Publication number
- GB2172889A GB2172889A GB08606632A GB8606632A GB2172889A GB 2172889 A GB2172889 A GB 2172889A GB 08606632 A GB08606632 A GB 08606632A GB 8606632 A GB8606632 A GB 8606632A GB 2172889 A GB2172889 A GB 2172889A
- Authority
- GB
- United Kingdom
- Prior art keywords
- reaction
- ester
- carbon atoms
- hydrogen atom
- phosphate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000002148 esters Chemical class 0.000 title claims abstract description 28
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 10
- 150000003839 salts Chemical class 0.000 claims abstract description 9
- 125000003709 fluoroalkyl group Chemical group 0.000 claims abstract description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 8
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 4
- 150000001340 alkali metals Chemical class 0.000 claims abstract description 4
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 4
- 125000001153 fluoro group Chemical group F* 0.000 claims abstract description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims abstract description 3
- 150000003973 alkyl amines Chemical class 0.000 claims abstract description 3
- 238000006243 chemical reaction Methods 0.000 claims description 56
- -1 dodecyl tetradecyl Chemical group 0.000 claims description 35
- 229910019142 PO4 Inorganic materials 0.000 claims description 27
- 235000021317 phosphate Nutrition 0.000 claims description 27
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 24
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 claims description 22
- 239000010452 phosphate Substances 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 6
- 239000002184 metal Substances 0.000 claims description 6
- RPQRDASANLAFCM-UHFFFAOYSA-N oxiran-2-ylmethyl prop-2-enoate Chemical compound C=CC(=O)OCC1CO1 RPQRDASANLAFCM-UHFFFAOYSA-N 0.000 claims description 6
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims description 6
- 238000006116 polymerization reaction Methods 0.000 claims description 6
- 238000006386 neutralization reaction Methods 0.000 claims description 5
- 230000000865 phosphorylative effect Effects 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000003112 inhibitor Substances 0.000 claims description 4
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 239000002798 polar solvent Substances 0.000 claims description 3
- 229920000137 polyphosphoric acid Polymers 0.000 claims description 3
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 claims description 3
- GPNYZBKIGXGYNU-UHFFFAOYSA-N 2-tert-butyl-6-[(3-tert-butyl-5-ethyl-2-hydroxyphenyl)methyl]-4-ethylphenol Chemical compound CC(C)(C)C1=CC(CC)=CC(CC=2C(=C(C=C(CC)C=2)C(C)(C)C)O)=C1O GPNYZBKIGXGYNU-UHFFFAOYSA-N 0.000 claims description 2
- 239000002585 base Substances 0.000 claims description 2
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 235000019441 ethanol Nutrition 0.000 claims description 2
- 150000002440 hydroxy compounds Chemical class 0.000 claims description 2
- 125000002463 lignoceryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000001802 myricyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 230000003472 neutralizing effect Effects 0.000 claims description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 claims description 2
- 230000020477 pH reduction Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 11
- 229920000642 polymer Polymers 0.000 abstract description 10
- 150000001875 compounds Chemical class 0.000 description 38
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 238000004128 high performance liquid chromatography Methods 0.000 description 16
- 239000002253 acid Substances 0.000 description 15
- 239000007864 aqueous solution Substances 0.000 description 15
- 239000012528 membrane Substances 0.000 description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 238000013019 agitation Methods 0.000 description 10
- 239000011734 sodium Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 6
- 210000000170 cell membrane Anatomy 0.000 description 5
- 239000002502 liposome Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000178 monomer Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 150000003904 phospholipids Chemical class 0.000 description 4
- 229920005597 polymer membrane Polymers 0.000 description 4
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- QRIMLDXJAPZHJE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)CO QRIMLDXJAPZHJE-UHFFFAOYSA-N 0.000 description 3
- 239000004593 Epoxy Substances 0.000 description 3
- 229910007159 Si(CH3)4 Inorganic materials 0.000 description 3
- BPOJYIFQGNXRCW-UHFFFAOYSA-N [3-[dodecoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOP(O)(=O)OCC(O)COC(=O)C(C)=C BPOJYIFQGNXRCW-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000003999 initiator Substances 0.000 description 3
- 239000003094 microcapsule Substances 0.000 description 3
- 229940042880 natural phospholipid Drugs 0.000 description 3
- 239000003505 polymerization initiator Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 125000006519 CCH3 Chemical group 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 238000010587 phase diagram Methods 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- UPSJKWVICNHZIJ-UHFFFAOYSA-M sodium;1,1,2,2,3,3,4,4,5,5,6,6,7,7,10,10,10-heptadecafluorodecyl [2-hydroxy-3-(2-methylprop-2-enoyloxy)propyl] phosphate Chemical compound [Na+].CC(=C)C(=O)OCC(O)COP([O-])(=O)OC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)CCC(F)(F)F UPSJKWVICNHZIJ-UHFFFAOYSA-M 0.000 description 2
- SFQRSHQHSUFUFR-UHFFFAOYSA-M sodium;dodecyl [2-hydroxy-3-(2-methylprop-2-enoyloxy)propyl] phosphate Chemical compound [Na+].CCCCCCCCCCCCOP([O-])(=O)OCC(O)COC(=O)C(C)=C SFQRSHQHSUFUFR-UHFFFAOYSA-M 0.000 description 2
- KOWOGKUTCSIJFZ-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5,5,6,6,7,7,10,10,10-heptadecafluorodecyl dihydrogen phosphate Chemical compound OP(O)(=O)OC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)CCC(F)(F)F KOWOGKUTCSIJFZ-UHFFFAOYSA-N 0.000 description 1
- DKEGCUDAFWNSSO-UHFFFAOYSA-N 1,8-dibromooctane Chemical compound BrCCCCCCCCBr DKEGCUDAFWNSSO-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- YOVHQGWAWNZGMZ-UHFFFAOYSA-N 2-decyltetradecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCC(COP(O)(O)=O)CCCCCCCCCC YOVHQGWAWNZGMZ-UHFFFAOYSA-N 0.000 description 1
- YPFIYMHYZDIPAR-UHFFFAOYSA-L 2-hexyldecyl phosphate Chemical compound CCCCCCCCC(COP([O-])([O-])=O)CCCCCC YPFIYMHYZDIPAR-UHFFFAOYSA-L 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229910002567 K2S2O8 Inorganic materials 0.000 description 1
- DHCGNXDXGPMUER-UHFFFAOYSA-N [1,1,2,3,3,4,4,5,5,6,10,10,10-tridecafluoro-2-(1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluorohexyl)decyl] dihydrogen phosphate Chemical compound C(CC(C(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(C(OP(=O)(O)O)(F)F)F)(F)F)(F)F)(F)F)F)CC(F)(F)F DHCGNXDXGPMUER-UHFFFAOYSA-N 0.000 description 1
- ZZOXJUJIKMTYGM-UHFFFAOYSA-L [Na+].[Na+].FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(O)(COP([O-])([O-])=O)C(OC(=O)C(=C)C)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)CCCCC(F)(F)F Chemical compound [Na+].[Na+].FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(O)(COP([O-])([O-])=O)C(OC(=O)C(=C)C)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)CCCCC(F)(F)F ZZOXJUJIKMTYGM-UHFFFAOYSA-L 0.000 description 1
- 239000003012 bilayer membrane Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003633 blood substitute Substances 0.000 description 1
- BNMJSBUIDQYHIN-UHFFFAOYSA-N butyl dihydrogen phosphate Chemical compound CCCCOP(O)(O)=O BNMJSBUIDQYHIN-UHFFFAOYSA-N 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- YVIGPQSYEAOLAD-UHFFFAOYSA-L disodium;dodecyl phosphate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOP([O-])([O-])=O YVIGPQSYEAOLAD-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- TVACALAUIQMRDF-UHFFFAOYSA-N dodecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCOP(O)(O)=O TVACALAUIQMRDF-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 239000003014 ion exchange membrane Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- UHGIMQLJWRAPLT-UHFFFAOYSA-N octadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCCCOP(O)(O)=O UHGIMQLJWRAPLT-UHFFFAOYSA-N 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 235000019394 potassium persulphate Nutrition 0.000 description 1
- IXUKOUCGFJHNHH-UHFFFAOYSA-M potassium;2-decyltetradecyl [2-hydroxy-3-(2-methylprop-2-enoyloxy)propyl] phosphate Chemical compound [K+].CCCCCCCCCCCCC(CCCCCCCCCC)COP([O-])(=O)OCC(O)COC(=O)C(C)=C IXUKOUCGFJHNHH-UHFFFAOYSA-M 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 1
- VFLHLPHXPXIECB-UHFFFAOYSA-M sodium;2-hexyldecyl [2-hydroxy-3-(2-methylprop-2-enoyloxy)propyl] phosphate Chemical compound [Na+].CCCCCCCCC(CCCCCC)COP([O-])(=O)OCC(O)COC(=O)C(C)=C VFLHLPHXPXIECB-UHFFFAOYSA-M 0.000 description 1
- QYDKAIGMWMMKKU-UHFFFAOYSA-M sodium;butyl [2-hydroxy-3-(2-methylprop-2-enoyloxy)propyl] phosphate Chemical compound [Na+].CCCCOP([O-])(=O)OCC(O)COC(=O)C(C)=C QYDKAIGMWMMKKU-UHFFFAOYSA-M 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F30/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
- C08F30/02—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
Abstract
Phosphoric esters of the following general formula <IMAGE> in which R' represents a hydrogen atom or a methyl group, R represents a linear or branched alkyl group having from 1 to 36 carbon atoms or a linear or branched fluoroalkyl group at least one hydrogen atom of which is substituted with a fluorine atom and which has from 1 to 36 carbon atoms, and M represents a hydrogen atom, an alkali metal, ammonium, or a salt of an alkylamine or an alkanolamine, have good surface activity, self-organizability and polymerizability, and are highly safe to the human body. When polymerized, the resulting polymers have wide utility in the engineering and medical fields.
Description
SPECIFICATION
Phosphoric esters 1) Field of the invention
This invention relates to novel phosphoric esters and more particularly to phosphoric esters having good surface activity, self-organizability (which may be hereinafter referred to simply as S.O.), and polymerizability.
2) Description of the prior art
Cells are the minimum unit of a living body and are covered with cell membranes. This cell membrane has various functions such as cell separation, sectional formation, cell movement, transport of substances, transmission of information and the like, and is a source of life activity.
On the other hand, in the field of polymer chemistry, intensive studies have been recently made on synthetic polymer membranes which have such functions as the cell membranes in order to apply the polymer membranes to wide fields such as of engineering, medical science, and pharmacology.
For instance, studies have been made on separation membranes of polymers having the function of substance transport. In the field of engineering, artificial polymer membranes have now been widely used industrially as ion-exchange membranes, membranes for dialysis, membranes for ultrafiltration, gas separation membranes, membranes for reverse osmosis and the like. In the medical field, extensivestudies have been made on solute-permeable membranes for purification of blood as used in artificial kidney, gas permeable membranes for purification of blood as used in artificial lung, and the like.
Moreover, studies of microcapsules having the section-protective function have been made. Artificial polymer membranes have been applied, for example, to microcapsulation of perfumes and duplicating papers in which inks are microcapsulated.
For the application of microcapsules having a permeating function, there have been studied microcapsulation of a drug derivery system or carrier of enzymes, artificial erythrocyte and the like.
It has been revealed that cell membranes have a bimolecular phospholipids membrane. Accordingly, natural phospholipids (natural liposomes) are used to make a bilayer vesicle similar to a cell membrane and the vesicle is utilized as a model substance of a vital membrane in order to elucidate various phenomena in biological membranes. The biological membrane is systematically oriented by the physical property of phospholipid molecules, or the property of self-gathering and organization inherent to an amphiphilic compound having both hydrophobic and hydrophilic groups and thus, forms a bilayer structure.
Thus, known artificial polymer membranes are completely different in structure from biological membranes.
In recent years, however, a variety of compounds have been found which have S.O. and are capable of forming a bilayer membrane structure, including not only natural phospholipids, but also synthetic compounds. Accordingly, artificial liposomes could be prepared using synthetic compounds. Moreover, polymeric liposomes in which the bilayer structure is stabilized by polymerization have been extensively studied. For this purpose, there has been prepared a compound, used as a monomer, having a polymerizable hydrophobic or hydrophilic group, e.g. a compound of the following formula (IV) was prepared by
Regan et al [Journal of the American Chemical Society, 105,2975(1983)].
These natural, artificial and polymer liposomes are considered to be a kind of microcapsule and the application of these liposomes to engineering and medical sciences in the future is now expected. In consideration of monomers as a material for the membrane, such monomers should have not only good chemical properties, but also surface activity and physical properties such as S.O. In addition, the monomers should favorably have good biocompatibility on future application for biomedical use. Natural phospholipids just have desired functions or properties such as surface activity, S.O., biocompatibility and the like, and compounds obtained by introducing polymerizable groups into phospholipids have been noticed more and more.
Since phospholipids of high purity are difficult to obtain and expensive, there is a demand of a development phosphoric ester monomers which are easy to prepare industrially and which have good surface activity, S.O. and polymerizability and are highly safe to human body.
Summary of the invention
Under these circumstances in the art, the present inventors have intensively made studies and, as a result, found that novel phosphoric esters having a specific group have good surface activity, S.O. and polymerizability. The resulting polymers have good film formability and antistaticity. The esters can be synthesized from inexpensive and readily available starting materials in high yield and high purity. The present invention is accomplished based on the above finding.
According to the present invention, there is provided a phosphoric ester of the following general formula (I)
in which R' represents a hydrogen atom or a methyl group, R represents a linear or branched alkyl group having from 1 to 36 carbon atoms or a linear or branched fluoroalkyl group at least one hydrogen atom of which is substituted with a fluorine atom and which has from 1 to 36 carbon atoms, and M represents a hydrogen atom, an alkali metal, ammonium, or a salt of an alkylamine or an alkanolamine.
Brief description of the drawings
Figure 1 is a phase diagram of a phosphoric ester compound (V)/H2O system of the invention.
Figure 2 is an IR spectrum diagram of the compound (V).
Detailed description of the invention and preferred embodiments
In Japanese Patent Publication No. 55-2235, there is described an adhesive for human hard tissue which comprises a polymer of a phosphoric ester having at least one polymerizable functional group.
The phosphoric ester having at least one polymerizable functional group may be within the scope of the compound of the above general formula (I) according to the invention. However, in the above patent publication, the compound of the formula (I) is not particularly described and the polymer is used as an adhesive. In this sense, the compound (I) of the invention is believed to be a novel compound.
The phosphoric esters of the general formula (I) of the invention can be readily prepared, for example, by a process in which glycidyl methacrylate or acrylate of the formula (Ill) is reacted with a monoaikali metal salt of a monoalkyl phosphate of the formula (II) according to the following reaction formula to obtain a phosphoric ester (la), which is, if necessary, subjected to acidification and neutralization with a base.
in which M' represents an alkali metal, and R and R' have the same meanings as defined before, respectively.
In the phosphoric esters of the formula (I), the linear or branched alkyl groups having from 1 to 36 carbon atoms and represented by R include, for example, methyl, ethyl, butyl, octyl, decyl, dodecyl tetradecyl, hexadecyl, octadecyl, docosyl, tetracosyl, triacontyl, 2-ethylhexyl, 2-hexyldecyl, 2-octyldodecyl, 2decyltetradecyl, 2-undecylhexadecyl, 2-tetradecyloctadecyl, emery-isostearyl and the like groups.
The fluoroalkyl groups whose at least one hydrogen group is substituted with a fluorine atom include, for example, tridecafluorooctyl, heptadecafluorododecyl, heneicosafluorododecyl, pentacosafluorotetrade- cyl, nonacosafluoro hexadecyl, tritriacontafl uorooctadecyl, 2-pentafl uo roethyl pentafl uoroh exyl, 2tridecafluorohexyltridecafluorodecyl, 2-heptadecafluorooctylheptadecafluorododecyl, 2 heneicosafluorodecylheneicosafluorotetradecyl, 2-pentacosafluorododecylpentacosafluorohexadecyl, 2 nonacosafluorotetradecylnonacosafluorooctadecyl and the like groups.
These alkyl or fluoroalkyl groups should preferably have from 8 to 36 carbon atoms in view of surface activity and S.O. Most preferably, there are used dodecyl, hexadecyl, octadecyl, 2-hexyldecyl, 2-octyldodecyl, 2-decyltetradecyl, tridecafluorooctyl, heptadecafluorodecyl, heneicosafluorododecyl, and 2tridecafluorohexyltridecafluorodecyl groups.
In the practice of the invention, these alkyl and fluoroalkyl groups are called "alkyl group".
In the formula (I), R' is preferably methyl group.
The monoalkyl phosphates of the formula (II) in the above reaction formula are prepared by reacting a phosphorylating agent, such as phosphorus pentaoxide, phosphorus oxychloride, polyphosphoric acid or the like, with organic hydroxy compounds having corresponding alkyl groups to obtain monoalkyl phosphates and neutralizing the phosphates. The monoalkyl phosphates (II) may be prepared by any methods, but should preferably have a high purity. If the monoalkyl phosphate (II) has a low purity and contains large amounts of secondarily produced impurities, the following problems may be involved.
When dialkyl phosphates which are secondarily produced when using phosphorylating agents such as phosphorus pentaoxide and phosphorus oxychloride are contained, the surface activity and S.O. of the monoalkyl phosphate lower or even disappear. Further, in a subsequent reaction with epoxy compounds, the purity of an intended compound lowers with the attendant disadvantage that it becomes difficult to obtain the intended compound of high purity by purification.
Orthophosphoric acid which are secondarily produced on use of polyphosphoric acid as the phosphorylating agent will lower the yield of reaction with epoxy compounds with a lowering of purity of an intended compound. In addition, purification is difficult for obtaining a highly pure intended compound.
Accordingly, the purity of the monoalkyl phosphate (II) should preferably be not less than 90 wt%. A process for industrially producing such a highly pure monoalkyl phosphate is preferably a process developed by some of the present inventors (Japanese Patent Application No. 59-138829).
The use of polyoxyethylene-added alkyl monophosphates instead of the monoalkyl phosphate (II) is not favorable because the polyoxyethylene-added alkyl monophosphate cannot be obtained in high purity.
Moreover, compounds obtained by using polyoxyethylene-added alkyl monophosphates have non-ionic (surface active) moieties in the molecule thereof and have thus poor S.O.
In the above reaction, glycidyl methacrylate or glycidyl acrylate (III) should preferably be used in an amount of from 1 to 10 moles, most preferably from 3 to 5 moles, per mole of the monoalkali metal salt of monoalkyl phosphate (Il).
If the reaction is effected without conversion of the monoalkyl phosphate into the monoalkali metal salt, a trialkyl phosphate formed by reaction of additional 1 mole of compound (III) is by-produced along with an intended compound. The reaction system after completion of the reaction is acidic, so that the ester bonds are apt to suffer hydrolysis, with a lowering in yield of the intended compound. In order to carry out the reaction, it is essential that the monoalkyl phosphate be used in the form of a monoalkali metal salt.
The solvents used for the reaction should preferably inert polar solvents including, for example, water, methyl alcohol, ethyl alcohol and the like, of which water is most preferable.
The reaction temperature is generally in the range of from 30 to 100 C, preferably from 50 - 90"C.
On reaction, polymerization inhibitors or retarders may be added and include, for example, hydroquinone monomethyl ether, hydroquinone, 2,2'-methylenebis (4-ethyl-6-t-butylphenol) and the like. These agents are preferably used in an amount of from 50 to 10000 ppm of glycidyl methacrylate or acrylate.
The resulting reaction solution contains, aside from a phosphoric ester which is an intended compound, an unreacted compound of the formula (III) or a hydrolyzate thereof, which is glyceryl methacrylate. The reaction product obtained from the reaction solution may be used as it is depending on the use, and may be purified to obtained a highly pure product. For instance, with sodium salt of dodecyl 2-hydroxy-3-methacryloyloxypropyl phosphate [R' = CH3, R = C,2H2s, M = Na in the formula (I) and hereinafter referred to as compound (V)], a pure product can be obtained as follows.Glycidyl methacrylate is added for reaction to an aqueous solution of sodium dodecyl phosphate, followed by either removing the water by distillation or saturating the reaction solution with an electrolyte such as sodium chloride or potassium chloride, and extracting an organic matter in an organic solvent such as ethyl ether, and then distilling off the ether. Thereafter, unreacted glycidyl methacrylate is separated by extraction with a nonpolar solvent such as n-hexane, to which acetone is added to precipitate sodium salt of dodecyl 2-hydroxy-3-methacryloyloxypropyl phosphate, thereby separating glyceryl methacrylate, which is a hydrolyzate of glycidyl methacrylate, and is soluble in acetone, to obtain the intended product of high purity. It will be noted that after completion of the reaction, when unreacted glycidyl methacylate is completely hydrolyzed, a subsequent purification procedure becomes easy.
The acid-type dodecyl 2-hydroxy-3-methacryloyloxypropyl phosphate [R' = CHs, R = C,2H25, M = H in the formula (I)] is obtained by adding an acid such as, for example, hydrochloric acid to the aqueous solution of the Na salt to render the solution acidic, and extracting the phosphate by extraction with a solvent such as ethyl ether.
Depending on the reaction condition, there may be formed a small amount of a phosphoric ester of the following general formula (VI) aside from the phosphoric ester of the general formula (I).
in which R', R and M have the same meanings as defined before, respectively.
The compounds of the formula (I) have surface activity and S.O., and this will be seen from Figure 1 showing a phase diagram in an aqueous system of the compound (V), revealing that liquid crystal is formed. The polymerizability of the compound of the invention is confirmed from the fact that when a photopolymerization initiator or an ordinary aqueous polymerization initiator is added, for example, to an aqueous solution of the compound (V) and light or heat is applied to the solution, polymerization takes place and the resulting polymer has film formability.
The phosphoric esters of the invention have surface activity, S.O. and polymerizability and are substantially harmless against human body. In addition, the esters can be prepared in an industrially, very advantageous manner. Accordingly, they has wide utility in the engineering and medical fields.
The present invention is described by way of examples.
Example 1
Two hundreds grams of monododecyl phosphate having a purity of 97% [0.73 moles, AV1 (mg of KOH necessary for neutralization of 1 g of the phosphoric monoester sample to a first equivalence point) of this sample = 210.3, AV2 (mg of KOH necessary for neutralization of 1 g of the phosphoric monoester sample to a second equivalence point) = 420.8] was charged into a reactor, to which 750 ml of 1 N sodium hydroxide aqueous solution was added, followed by agitation and increasing the temperature to 70"C to obtain a uniform system. The acid value of the reaction system (mg of KOH necessary for neutralization of 1 g of sample) was found to be 42.9. Thereafter, while the reaction system was maintained at 70"C, 533 g (3.75 moles) of glycidyl methacrylate was gradually added, followed by agitation at the temperature for 9 hours.At this time, the acid value of the reaction system was approximately zero, revealing that the reaction was completed. The sample from the reaction system was subjected to the
HPLC (high-pressure liquid chromatography), revealing the peak of unreacted glycidyl methacrylate. Agitation was further continued to a total reaction time of 20 hours, at which glycidyl methacrylate was completely hydrolyzed. The reaction solution was cooled down to room temperature and charged into a separating funnel, followed by saturation with sodium chloride and extraction twice with each 500 g of ethyl ether.The ethyl ether was distilled off under a reduced pressure, and 500 g of acetone was added to the resulting non-volatile liquid residue, followed by allowing to chill at 5"C. After one day, separated crystals were collected and recrystallized from acetone to obtain 178 g of white crystals of sodium dodecyl 2-hydroxy-3-methacryloyloxypropyl phosphate.
aH-NMR: 8 0.8 ppm (t, 3H, -P-OCH2(CH2)10CH3) 81.2 ppm (broad s, 20H,-P-OCH2(CH2).oCH3) 8 2.0 ppm (s, 3H, CH2=C-CH3) 8 3.7 -4.3 ppm (broad, 8H,
8 5.5 ppm (broad s, 1H,
5 6.1 ppm (broad s, 1H,
13C-NMR
5 (ppm): n 14.1, a 18.3, m 23.0, j 26.1, ik 30.2, t 32.3, g 65.2, e 68.7, b 126.5, c 136.2
Standard sample: Si(CH3)4
IR (KBr):
Figure 2
Elementary Analysis c/o Hol P(%) Na(%) Found 52.53 8.38 7.2 5.3
Calculated 53.02 8.43 7.2 5.3
The results of the HPLC analysis revealed that the purity was 98 to 99%.
Test Example 1
To a mixture of the sodium dodecyl 2-hydroxy-3-methacryloyloxypropyl phosphate [compound (V)] obtained in Example 1 and water in 50/50 was added benzoin isobutyl ether, as a photopolymerization initiator, in an amount of 2% of the compound (V), followed by light irradiation for 2 hours in a stream of nitrogen, thereby obtaining a colorless transparent rubber-like material. This sample [sample of the mixture of compound (V) and water in 50/50 to which the photopolymerization initiator was added] was sandwiched between slide glasses and thus made thin, followed by light irradiation for 2 hours in the same manner as mentioned above, thereby obtaining a colorless transparent film-like material.
Alternatively, K2S2O8 as polymerization initiator was added to an aqueous solution of about 10% compound (V) in an amount of 1% of the compound (V), followed by heating at 60 to 70"C for 4 to 5 hours, thereby obtaining a colorless, transparent, highly viscous aqueous solution. This polymer product was placed on a slide glass and allowed to stand to obtain a colorless transparent film-like material. This polymer product was capable of being gelled in water or methanol.
Example 2
In the same manner as in Example 1, 200 g (0.55 moles) of monooctadecyl phosphate having a purity of 97% (AV1 = 160.7, AV2 = 321.5) was dissolved in 573 ml of 1 N sodium hydroxide aqueous solution at 55"C (at which the acid value of the reaction system was 40.3), to which 407 g (2.86 moles) of glycidyl methacrylate was gradually added, followed by agitation at the temperature for 20 hours. The acid value of the reaction system was approximately zero, revealing that the reaction rate of the monalkyl phosphate was approximately 100%. Subsequently, the reaction solution was cooled down to 0 C and the resulting crystals were collected by filtration. The filter cake was washed with acetone and dried to obtain 198 g of white crystals of sodium octadecyl 2-hydroxy-3-methyacryloyloxypropyl phosphate.
Elementary Analysis: C(%) H(%) P(%) Na(%) Found 58.22 9.28 5.9 4.5
Calculated 58.35 9.40 6.0 4.5
The results of the analysis of HPLC revealed that the purity was over 99%.
Example 3
Twenty grams (0.057 moles) of mono-2-hexyldecyl phosphate having a purity of 92% (AV1 = 167.2,
AV2 = 329.8) was dispersed in 59.6 ml of 1 N sodium hydroxide aqueous solution (at which the acid value of the reaction system was 39.5), to which 25.4 g (0.178 moles) of glycidyl methacrylate was gradually added at 70"C, followed by agitation at the temperature for 30 hours. The acid value of the reaction system was approximately 1.1, revealing that the reaction rate of the monoalkyl phosphate was approximately 97%. Subsequently, the reaction solution was analyzed by HPLC with the result that peaks of the hydrolyzate of glycidyl methacrylate and a new product were observed.The product was separated from the reaction solution by HPLC and the solvent was distilled off under reduced pressure to 23.5 g of sodium 2-hexyldecyl 2-hydroxy-3-methacryloyloxypropyl phosphate.
1H-NMR: # 0.9 ppm (t, 6H, -CH2CH3 x 2) 61.3 ppm (broad s, 24H,
1.9 ppm (s, 3H, CH2 = C-CH,) 8 3.4 - 4.5 ppm (broad, 9H,
8 5.5 ppm (broad s, 1H,
8 6.1 ppm (broad s, 1H,
13C-NMR:
8(ppm): q 14.2, a 18.3, p 22.7, k 27.0, n 29.8, m 30.1, j 30.8, e 31.1, o 32.0, i 38.6, g 64.8, f 65.6, e 68.2, h 71.1, b 126.3, c 136.1, d 167.5.
Standard sample: Si(CH3)4
Elementary Analysis: C(%) H(%) P (%) Na(%) Found 56.56 8.88 6.4 5.0
Calculated 56.78 9.12 6.4 4.7
The results of the HPLC analysis revealed that the purity was 98 to 99%.
Example 4
Twenty grams (0.043 moles) of mono-2-decyltetradecyl phosphate having a purity of 94% (AV1 = 134.2, AV2 = 267.1) was charged into a reactor, to which 47.8 ml of 1 N potassium hydroxide aqueous solution was added and agitated, followed by increasing the temperature to 70"C to form a uniform dispersion (at which the acid value of the reaction system was 37.9). While keeping the reaction system at 70"C, 20.4 g (0.143 moles) of glycidyl methacrylate was gradually dropped, followed by agitation at the temperature for 20 hours. The acid value of the reaction system was approximately 1.5, revealing that the reaction rate of the monoalkyl phosphate was about 96%.The resulting product was collected by HPLC and the solvent was distilled off under reduced pressure to obtain 23.4 g of potassium 2-decyltetradecyl 2-hyd roxy-3-methacryloyloxypropyl phosphate.
Elementary Analysis: C ( /0) Hol f /0) Na(%) Found 60.23 9.61 5.0 6.1
Calculated 60.55 9.84 5.0 6.4
The results of the analysis of HPLC revealed that the purity was 98 to 99%.
Example 5
Twenty grams (0.13 moles) of monobutyl phosphate having a purity of 99% (AV1 = 360.6, AV2 = 721.3) was charged into a reactor, to which 129 ml of 1 N sodium hydroxide aqueous solution was added and agitated, followed by dissolution at 70"C (at which the acid value of the reaction system was 46.7).
While keeping the reaction system at 700C, 91.4 g (0.64 moles) of glycidyl methacrylate was gradually dropped, followed by agitation at the temperature for 20 hours. The acid value of the reaction system was approximately zero, revealing that the reaction rate of the monoalkyl phosphate was approximately 100%. The resulting product was collected by HPLC and the solvent was distilled off under reduced pressure to obtain 37.2 g of sodium butyl 2-hydroxy-3-methacryloyloxypropyl phosphate.
Elementary Analysis: c/o { /0) P { /0) Naf /O) Found 41.03 6.28 9.6 7.2
Calculated 41.52 6.33 9.7 7.2
The results of the analysis of HPLC revealed that the purity was 98 to 99%.
Example 6
95.5 g (0.19 moles) of heptadecafluorodecyl phosphate having a purity of 97% (AV1 = 108.9, AV2 = 217.0) was charged into a reactor, to which 185 ml of 1 N sodium hydroxide aqueous solution was added and agitated, followed by heating to 700C to make a uniform system. The acid value of the reaction system was 36.8. While keeping the reaction system at 70 C, 104.5 g (0.74 moles) of glycidyl methacrylate was gradually added, followed by agitation at the temperature for 9 hours, at which the acid value of the reaction system was approximately zero, revealing that the reaction was completed. The sample was analyzed by HPLC with the result that a peak of unreacted glycidyl methacrylate was observed.Agitation was further continued to a total time of 20 hours, at which it was found that glycidyl methacrylate was hydrolyzed completely and that peaks of glyceryl methacrylate which was a hydrolyzed product at the epoxy moiety and of an intended compound were recognized. The reaction solution was cooled down to room temperature, to which 200 g of acetone was added, followed by cooling to -5 C to obtain 92 g (yield 70%) of heptadecafluorodecyl 2-hydroxy-3-methacryloyloxypropyl phosphate sodium salt.
aH-NMR: 8 2.0 ppm (s, 3H, CH2 = C-CH3) 8 2.6 ppm (tt, 2H, -P-OCH2CH2CF2-) 8 3.5 - 4.5 ppm (m, 7H,
8 5.6 ppm (broad s, 1H,
6.1 ppm (broad s, 1H,
13C-NMR:
8 (ppm): a 18.5, i 33.4, h 58.7, e 66.5, g 67.6, f 69.9, b 126.5, c 137.6, d 168.9.
Standard sample: Si(CH3)4
Elementary Analysis: C(%) H(%) F(%) P(%) Na(%) Found 28.53 2.33 45 4.3 3.3
Calculated 28.83 2.13 46 4.4 3.3
The results of the HPLC analysis revealed that the purity was 98 to 99%.
Test Example 2 K2S2Os as a polymerization initiator was added to an aqueous solution of about 10% of sodium heptadecafluorodecyl 2-hydroxy-3-methacryloyloxypropyl phosphate [compound (Vl)] obtained in Example 6 in an amount of 1% of the compound (VI), followed by heating at 60 to 70 C for 4 to 5 hours, thereby obtaining a colorless, transparent, highly viscous aqueous solution. The polymerized product was placed on a slide glass and allowed to stand to obtain a colorless transparent film-like material.
This highly viscous aqueous solution had an anisotropic property and a systematic liquid crystal structure.
Example 7
Twenty grams (0.025 moles) of 2-tridecafluorohexyltridecafluorodecyl phosphate having a purity of 92% (AV1 = 70.1, AV2 = 139.8) was dispersed in 24.8 ml of 1 N sodium hydroxide aqueous solution (at which the acid value of the reaction system was 31.1), to which 14.2 g (0.10 mole) of glycidyl methacrylate was gradually added at 70 C, followed by agitation at the temperature for 30 hours. At this time, the acid value of the reaction system was approximately zero, revealing that the reaction rate of the monoalkyl phosphate was approximately 100%. The reaction solution was analyzed by HPLC, revealing that peaks of the hydrolyzate of glycidyl methacrylate and a new compound were found. The resulting product was collected by HPLC and the solvent was distilled off under reduced pressure to obtain 21.5 g (yield 89%) of sodium 2-tridecafluorohexyltrideca-fluorodecyl-2-hydroxy-3-methacryloyloxypropyl phosphate.
Elementary Analysis:
C (%) H (%) F (%) P (%) Na(%)
Found 28.71 1.52 50 3.1 2.7
Calculated 29.07 1.49 52 3.3 2.4
The results of the analysis of HPLC revealed that the purity was 98 to 99 /O.
Claims (19)
1. A phosphoric ester of the general formula (I)
in which R' represents a hydrogen atom or a methyl group, R represents a linear or branched alkyl group having from 1 to 36 carbon atoms or a linear or branched fluoroalkyl group at least one hydrogen atom of which is substituted with a fluorine atom and which has from 1 to 36 carbon atoms, and M represents a hydrogen atom, an alkali metal, ammonium or a salt of an alkylamine or an alkanolamine.
2. An ester as claimed in claim 1 wherein the linear or branched alkyl group having 1 to 36 carbon atoms is selected from one or more of methyl, ethyl, butyl, octyl, decyl, dodecyl tetradecyl, hexadecyl, octadecyl, docosyl, tetracosyl, triacontyl, 2-ethylhexyl, 2-hexyldecyl, 2-octyldodecyl, 2-decyltetradecyl, 2 undecylhexadecyl, 2-tetradecyloctadecyl and emery-isostearyl.
3. An ester as claimed in claim 1 or claim 2 characterised in that the fluoroalkyl groups are selected from one or more of tridecafluorooctyl, heptadecafluorododecyl, heneicosafluorododecyl, pentacosafluorotetradecyl, nonacosafluorohexadecyl, tritriacontrafluorooctadecyl, 2-pentafluoroethylpentafluorohexyl, 2-tridecafluorohexyltridecafluorodecyl, 2-heptadecafluorooctylheptadecafluorododecyl, 2 heneicosafluorodecylheneicosafluorotetradecyl, 2-pentacosafluorododecylpentacosafluorohexadecyl, and 2-nonacosafluorotetradecylnonacosafluorooctadecyl.
4. An ester as claimed in any preceding claims wherein the alkyl and fluoroalkyl groups each have from 8 to 36 carbon atoms.
5. An ester as claimed in any preceding claim characterised in that R' is a methyl group.
6. A process for the production of a phosphoric ester as claimed in any one of the preceding claims in which a glycidyl methacrylate or acrylate having the general formula:
is reacted with a monoalkali metal salt of a monoalkyl phosphate having the general formula (II)
to produce a phosphoric ester.
7. A process as claimed in claim 6 wherein the phosphoric ester is subjected to acidification and/or neutralization with a base.
8. A process as claimed in claim 6 or claim 7 wherein the monoalkyl phosphates are prepared by reacting a phosphorylating agent with organic hydroxy compounds having corresponding alkyl groups to obtain monoalkyl phosphates and neutralizing the phosphates.
9. A process as claimed in claim 8 wherein the phosphorylating agent is selected from one or more of phosphorus pentaoxide, phosphorus oxychloride and polyphosphoric acid.
10. A process as claimed in any one of claims 6 to 9 characterised in that the glycidyl methacrylate or glycidyl acrylate is present in an amount of 1 to 10 moles per mole of monoalkali metal salt of monoalkyl phosphate.
11. A process as claimed in any one of claims 6 to 10 wherein the reaction is carried out in the presence of an inert polar solvent.
12. A process as claimed in claim 11 wherein the inert polar solvent is selected from one or more of water, methyl alcohol and ethyl alcohol.
13. A process as claimed in any one of claims 6 to 11 wherein the reaction is carried out at a temper ature within the range of 30"C to 100 C.
14. A process as claimed in any one of claims 6 to 13 wherein the reaction is carried out at a temperature within the range of 50"C to 90"C.
15. A process as claimed in any one of claims 6 to 14 wherein the reaction is carried out in the present of polymerization inhibitors and/or retarders.
16. A process as claimed in claim 15 wherein the polymerization inhibitors or retarders are present in an amount of 50 to 10000 ppm of glycidyl methacrylate or glycidyl acrylate.
17. A process as claimed in claim 15 or claim 16 wherein the polymerization inhibitors or retarders are selected from one or more of hydroquinone monomethyl ether, hydroquinone, 2,2'-methylenebis (4ethyl-6-t-butylphenol).
18. Phosphoric esters and methods of preparing them substantially as described in any one of the specific examples hereinbefore set forth.
19. Each and every novel embodiment substantially as herein described taken either separately or in combination.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5702585A JPS61215398A (en) | 1985-03-20 | 1985-03-20 | Phosphoric ester |
Publications (3)
Publication Number | Publication Date |
---|---|
GB8606632D0 GB8606632D0 (en) | 1986-04-23 |
GB2172889A true GB2172889A (en) | 1986-10-01 |
GB2172889B GB2172889B (en) | 1988-11-02 |
Family
ID=13043889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08606632A Expired GB2172889B (en) | 1985-03-20 | 1986-03-18 | Phosphoric esters |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPS61215398A (en) |
DE (1) | DE3609491A1 (en) |
GB (1) | GB2172889B (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2179666B (en) * | 1985-07-12 | 1989-10-25 | Kao Corp | Thickening aqueous electrolyte solutions with a polymer having phosphate groups |
EP0374831A2 (en) * | 1988-12-22 | 1990-06-27 | Kao Corporation | Phosphoric esters |
US5147938A (en) * | 1991-04-02 | 1992-09-15 | Minnesota Mining And Manufacturing Company | Acrylate adhesives containing polymerizable fluorochemical surfactants |
US5344930A (en) * | 1989-06-22 | 1994-09-06 | Alliance Pharmaceutical Corp. | Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties |
US5468812A (en) * | 1991-04-02 | 1995-11-21 | Minnesota Mining And Manufacturing Company | Polymerizable fluorochemical surfactants |
FR2873375A1 (en) * | 2004-07-22 | 2006-01-27 | Specific Polymers Sarl | New phosphone monomers (prepared by reacting a monomer with a dialkylphosphone epoxide) useful in the preparation of the copolymers, which are useful in e.g. anticorrosion, adhesion or fireproofing effects |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102342324B1 (en) * | 2020-12-11 | 2021-12-23 | 애경케미칼주식회사 | Fluoronated surfantant composition |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1581810A (en) * | 1977-04-20 | 1980-12-17 | Max Planck Gesellschaft | Process for the preparation of phospholipids |
EP0036155A2 (en) * | 1980-03-17 | 1981-09-23 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Polymerisable phospholipids, process for their preparation, polymeric phospholipids, process for their preparation as well as the use of the polymeric phospholipids |
-
1985
- 1985-03-20 JP JP5702585A patent/JPS61215398A/en active Pending
-
1986
- 1986-03-18 GB GB08606632A patent/GB2172889B/en not_active Expired
- 1986-03-20 DE DE19863609491 patent/DE3609491A1/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1581810A (en) * | 1977-04-20 | 1980-12-17 | Max Planck Gesellschaft | Process for the preparation of phospholipids |
EP0036155A2 (en) * | 1980-03-17 | 1981-09-23 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Polymerisable phospholipids, process for their preparation, polymeric phospholipids, process for their preparation as well as the use of the polymeric phospholipids |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2179666B (en) * | 1985-07-12 | 1989-10-25 | Kao Corp | Thickening aqueous electrolyte solutions with a polymer having phosphate groups |
EP0374831A2 (en) * | 1988-12-22 | 1990-06-27 | Kao Corporation | Phosphoric esters |
EP0374831A3 (en) * | 1988-12-22 | 1990-08-08 | Kao Corporation | Phosphoric esters |
US4994581A (en) * | 1988-12-22 | 1991-02-19 | Kao Corporation | Phosphoric esters |
US5344930A (en) * | 1989-06-22 | 1994-09-06 | Alliance Pharmaceutical Corp. | Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties |
US5147938A (en) * | 1991-04-02 | 1992-09-15 | Minnesota Mining And Manufacturing Company | Acrylate adhesives containing polymerizable fluorochemical surfactants |
US5468812A (en) * | 1991-04-02 | 1995-11-21 | Minnesota Mining And Manufacturing Company | Polymerizable fluorochemical surfactants |
FR2873375A1 (en) * | 2004-07-22 | 2006-01-27 | Specific Polymers Sarl | New phosphone monomers (prepared by reacting a monomer with a dialkylphosphone epoxide) useful in the preparation of the copolymers, which are useful in e.g. anticorrosion, adhesion or fireproofing effects |
Also Published As
Publication number | Publication date |
---|---|
JPS61215398A (en) | 1986-09-25 |
GB8606632D0 (en) | 1986-04-23 |
GB2172889B (en) | 1988-11-02 |
DE3609491A1 (en) | 1986-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20010043945A (en) | Organophosphorus compounds for dental polymerizable compositions | |
JP2877958B2 (en) | Ethylenically unsaturated compounds | |
EP0575717B1 (en) | A process for the preparation of glycerophospholipids | |
GB2172889A (en) | Phosphoric esters | |
US4736051A (en) | Process for the preparation of an alkali metal salt of a diester phosphoric acid | |
JP3052923B2 (en) | Method for producing (meth) acrylate derivative | |
JPS61129190A (en) | Polymerizable glycerophospholipid | |
US4751320A (en) | Phosphoric ester and process for producing same | |
US4740609A (en) | Phosphoric esters and process for preparing same | |
EP0242781B1 (en) | Phosphoric esters and process for preparing the same | |
JP3197787B2 (en) | Method for producing branched dimerized alkyl phosphate basic amino acid salt | |
US4774350A (en) | Phosphoric ester | |
DE69010169T2 (en) | Crystalline magnesium valproate and process for its production. | |
JPS62195390A (en) | Fluorine containing phosphoric acid ester | |
JP3171279B2 (en) | Method for producing alkylphosphocholine having 14 to 18 carbon atoms and method for purifying alkylphosphocholine | |
JPH0660184B2 (en) | Method for producing phosphate ester | |
JPH0641491B2 (en) | Method for producing a novel polymer containing a phosphate group | |
JPS62249994A (en) | Phosphoric acid ester and production thereof | |
JPH02238007A (en) | Compound and polymer having structure similar to natural phospholipid and production thereof | |
JPS62215549A (en) | Production of fatty acid ester | |
CN111057100A (en) | Preparation method of phosphatidylglycerol monosodium salt containing two different side chains | |
JPH064651B2 (en) | Phosphate ester and method for producing the same | |
WO1998054194A1 (en) | Process for producing (meth)acrylate derivatives | |
JPH05222069A (en) | Production of fluorine-containing phosphoric ester | |
JPS62148492A (en) | Production of alpha-dihydropolypulenyl monophosphate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19970318 |